Finance

Beta
Lists
SSKN:OTCMKTS
STRATA Skin Sciences Inc
$0.15
+0.60%
(+0.00090) 1D
Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SSKN...
Open
$0.15
High
$0.15
Low
$0.11
Mkt. cap
876.76K
Avg. vol.
19.16K
Volume
6.65K
52-wk high
$3.86
52-wk low
$0.11
EPS
-$1.35
Beta
-0.06
Shares outstanding
5.89M
No. of employees
114
Open
$0.15
High
$0.15
Low
$0.11
Mkt. cap
876.76K
Avg. vol.
19.16K
Volume
6.65K
52-wk high
$3.86
52-wk low
$0.11
EPS
-$1.35
Beta
-0.06
Shares outstanding
5.89M
No. of employees
114
News stories
From sources across the web
Profile
Strata Skin Sciences is an American medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations. The company's flagship product, XTRAC, is a medical device that allows for a trained dermatologist to treat skin conditions like Vitiligo and Psoriasis with monochromatic UV Light. Following completion of a successful conformity assessment procedure, Strata Skin Sciences has also been granted CE Mark approval for sale of MelaFind in the European Union. In July 2015, the company acquired PhotoMedex Inc. and is planning to relocate its headquarters from Irvington, New York to Horsham, Pennsylvania in Montgomery County. Wikipedia
About STRATA Skin Sciences Inc
CEO-
Employees114
FoundedJan 1, 1989
HeadquartersHorsham Township, Pennsylvania, United States
SectorMedical device
Websitestrataskinsciences.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
6.81M
7.66M
6.93M
9.29M
Cost of goods sold
3.16M
3.36M
2.74M
3.68M
Cost of revenue
3.16M
3.36M
2.74M
3.68M
Research and development expenses
96.00K
86.00K
172.00K
67.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.57M
6.44M
5.87M
5.51M
Operating expense
5.66M
6.53M
6.04M
5.58M
Total operating expenses
8.83M
9.89M
8.79M
9.26M
Operating income
-2.02M
-2.22M
-1.86M
37.00K
Other non operating income
-
-
-
-
EBT including unusual items
-2.43M
-2.49M
-1.62M
70.00K
EBT excluding unusual items
-2.43M
-2.49M
-2.31M
-381.00K
Income tax expense
-
-
-
12.00K
Effective tax rate
-
-
-
17.14%
Other operating expenses
-
-
-
-
Net income
-2.43M
-2.49M
-1.62M
58.00K
Net profit margin
-35.70%
-32.48%
-23.41%
0.62%
Earnings per share
-0.58
-0.60
-0.36
-
Interest and investment income
69.00K
226.00K
49.00K
66.00K
Interest expense
-486.00K
-491.00K
-498.00K
-484.00K
Net interest expenses
-417.00K
-265.00K
-449.00K
-418.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-795.00K
-1.01M
-993.00K
858.00K
Gain or loss from assets sale
34.00K
29.00K
20.00K
9.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer